Marelize Swart

An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3′-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients

Peter J. Smith, M. Skelton, L. Wiesner, 2016, Front. Genet..

The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients.

M. Ashton, C. Dandara, E. Bienvenu, 2014, Antiviral research.

CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics

M. Skelton, A. Wonkam, C. Dandara, 2012 .

Genetic variation in the 3′-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance

C. Dandara, Marelize Swart, M. Swart, 2014, Front. Genet..

A Global Health Diagnostic for Personalized Medicine in Resource-Constrained World Settings: A Simple PCR-RFLP Method for Genotyping CYP2B6 g.15582C>T and Science and Policy Relevance for Optimal Use of Antiretroviral Drug Efavirenz.

Farah Huzair, A. Wonkam, C. Dandara, 2015, Omics : a journal of integrative biology.

Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy.

T. Skaar, A. Chapman, R. Moorthi, 2019, Pharmacogenetics and genomics.

Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation

L. Kuhn, E. Abrams, A. Coovadia, 2015, BMC Infectious Diseases.

PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients

R. Ramesar, C. Dandara, Marelize Swart, 2012, BMC Medical Genetics.